Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 4/4/2020
SIETES contiene 92956 citas

 
 
 1 a 20 de 221 siguiente >>
Presentar resultados
Seleccionar todas
2.Enlace a cita original Cita con resumen
Qato DM, Ozenberger K, Olfson M. Prevalence of prescription medications with depression as a potential adverse effect among adults in the United States. JAMA 2018;319:12 de junio. [Ref.ID 102780]
3. Cita con resumen
Maier L, Pruteanu M, Kuhn M, Zeller G, Telzerow A, Anderson EE, Brochado AR, Fernandez KC, Dose H, Mori H, Patil KR, Bork P, Typas A. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 2018;555:29 de marzo. [Ref.ID 102577]
4.Enlace a cita originalTiene citas relacionadas Cita con resumen
Law SWY, Wong AYS, Anand S, Wong ICK, Chan EW. Neurospychiatric events associated with leukotriene-modifying agents: a systematic review. Drug Saf 2018;41:marzo. [Ref.ID 102559]
5. Cita con resumen
Henriksen DP, Davidsen JR, Laursen CB, Christiansen A, Damkier P, Hallas J, Pottegård A. Montelukast use — A 19-year nationwide drug utilisation study. Eur J Clin Pharmacol 2017;73:1297-304. [Ref.ID 102083]
6.Tiene citas relacionadas Cita con resumen
Aldea Perona A, García-Sáiz M, Sanz Álvarez E. Psychiatric disorders and montelukast in children: a disproportionality analysis of the VigiBase. Drug Saf 2016;39:69-78. [Ref.ID 100084]
7. Cita con resumen
Rudmik L, Soler ZM. Medical therapies for adult chronic sinusitis: a systematic review. JAMA 2015;314:926-39. [Ref.ID 99516]
8. Cita con resumen
Loymans RJB, Gemperli A, Cohen J, Rubinstein SM, Sterk PJ, Reddel HK, Jüni P, Ter Riet G. Comparative effectiveness of long term drug treatment strategies to prevent asthma exacerbations: network meta-analysis. BMJ 2014;348:g3009. [Ref.ID 98004]
9.Tiene citas relacionadas Cita con resumen
Anónimo. Comportements violents envers autrui sous l'effet de médicaments. Prescrire 2014;34:110-3. [Ref.ID 97126]
10.Tiene citas relacionadas Cita con resumen
Anónimo. Montelukast - Neuropsychiatric risks. Australian Prescriber 2013;4:1. [Ref.ID 95148]
11. Cita con resumen
Anónimo. Genes after LABA response. Prescribing Advice for GPs 2013:8 de enero. [Ref.ID 94621]
12. Cita con resumen
Anónimo. Long-acting beta2 agonists for childhood asthma. Australian Prescriber 2012;35:111-3. [Ref.ID 93160]
13. Cita con resumen
Parle J, Ross N, Jones J. Investigating beneficial drug reactions. BMJ 2012;344:35. [Ref.ID 92186]
14. Cita con resumen
15. Cita con resumen
16. Cita con resumen
Schumock GT, Lee TA, Joo MJ, Valuck RJ, Stayner LT, Gibbons RD. Association between leukotriene-modifying agents and suicide: what is the evidence?. Drug Saf 2011;34:533-44. [Ref.ID 90892]
17. Cita con resumen
Reuben A, Koch DG, Lee WM, Acute Liver Failure Study Group. Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. Hepatology 2010;52:2065-76. [Ref.ID 89970]
18. Cita con resumen
Cumming J, Mays N, Daubé J. How New Zealand has contained expenditure on drugs. BMJ 2010;340:1224-6. [Ref.ID 88636]
19. Cita con resumen
Lemanske Jr RF, Mauger T, Sorkness CA, Jackson DJ, Boehmer SJ, Martínez FD, Strunk RC, Szefler SJ, Zeiger RS, Bacharier LB, Covar RA, Guilbert TW, Larsen G, Morgan WJ, Moss MH, Spahn JD, Taussig LM, for the Childhood Asthma Research and Education (CARE) Network of the National Heart Lung and Blood Institute. Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids. N Engl J Med 2010;362:975-85. [Ref.ID 88070]
20. Cita con resumen
Wallestedt SM, Brunlöf G, Sundström A, Eriksson AL. Montelukast and psychiatric disorders in children. Pharmacoepidemiol Drug Saf 2009;18:858-64. [Ref.ID 86565]
Seleccionar todas
 
 1 a 20 de 221 siguiente >>